34
34 -- net promoter score for AstraZeneca (Q2 2025)
AstraZeneca received a Net Promoter Score (NPS) of 34 among surveyed US oncologists and hemato-oncologists in Q2 2025.
Questions about this data
What is the net promoter score for AstraZeneca?
The net promoter score for AstraZeneca is 34 as of Q2 2025 according to ZoomRx. This figure is the primary benchmark in the Lighthouse dataset for this segment. Individual results vary by region, channel mix, and audience quality.
What is a good net promoter score benchmark for AstraZeneca?
A strong net promoter score benchmark for AstraZeneca is 34, using the current serving value as of Q2 2025. This is one serving-eligible observation, not a distribution median; top-quartile comparisons require the underlying distribution. Vertical, audience size, and campaign type all shift what 'good' means.
How does AstraZeneca net promoter score compare to the industry average?
The published net promoter score serving value for AstraZeneca is 34 as of Q2 2025. Individual sectors and audiences may differ substantially; this single observation does not establish an aggregate mean. Quartile comparisons require the underlying distribution, which is not implied by this record.
What factors affect net promoter score for AstraZeneca?
Primary drivers of net promoter score variation for AstraZeneca include audience segmentation, timing, and channel selection. Methodology documents campaign factors, but this serving record does not quantify the effect of personalization. The current serving value is 34 as of Q2 2025.
What net promoter score should I aim for as a digital marketer in 2025?
For a digital marketer, the published net promoter score serving value is 34; it is an evidence-grade reference, not a personalized target as of Q2 2025. Any performance goal should account for channel mix and audience. Review the methodology before operational decisions; a gap from this serving value does not by itself indicate a structural issue.
Approved for serving with evidence grade B. The record passes the documented quality and serving gates; consult the methodology for provenance details.
Survey of 50 US-based oncologists and hemato-oncologists evaluating 19 manufacturers across five weighted dimensions.
<blockquote cite="https://lighthousedata.io/data/nps-astrazeneca-q2-2025" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>34</strong> -- net promoter score for AstraZeneca<br><small>Source: ZoomRx (Q2 2025) · <a href="https://lighthousedata.io/data/nps-astrazeneca-q2-2025" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.